https://pipelinereview.com/Hugel-America-Inc.-Announces-U.S.-FDA-Acceptance-of-Biologics-License-Application-BLA-for-LetibotulinumtoxinA-for-Injection-to-Treat-Glabellar-Frown-Lines/